| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.13B | 25.02B | 22.97B | 20.81B | 22.11B | 27.44B |
| Gross Profit | 14.70B | 16.34B | 18.73B | 16.51B | 18.06B | 22.93B |
| EBITDA | 8.99B | 10.83B | 4.39B | 3.67B | 4.10B | 6.97B |
| Net Income | 5.75B | 5.49B | 3.35B | 2.75B | 3.01B | 5.37B |
Balance Sheet | ||||||
| Total Assets | 516.48B | 487.08B | 417.74B | 383.69B | 368.07B | 326.60B |
| Cash, Cash Equivalents and Short-Term Investments | 368.98B | 18.23B | 173.97B | 163.72B | 174.81B | 143.41B |
| Total Debt | 112.18B | 211.34B | 46.46B | 90.87B | 75.11B | 84.43B |
| Total Liabilities | 431.65B | 407.36B | 336.34B | 304.93B | 290.67B | 262.46B |
| Stockholders Equity | 84.82B | 79.72B | 81.40B | 78.75B | 77.39B | 64.13B |
Cash Flow | ||||||
| Free Cash Flow | 17.07B | -7.60B | 2.18B | 20.37B | 21.31B | -11.02B |
| Operating Cash Flow | 17.39B | -7.28B | 2.48B | 21.46B | 21.62B | -10.58B |
| Investing Cash Flow | -3.94B | -4.78B | -24.47B | -13.07B | -16.02B | 18.49B |
| Financing Cash Flow | 31.45B | 18.05B | -1.71B | -4.14B | 160.68M | -6.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$154.10B | 5.14 | 10.09% | 0.97% | 8.40% | 78.28% | |
69 Neutral | HK$293.74B | 8.17 | 6.85% | 2.75% | 91.20% | 30.16% | |
68 Neutral | HK$181.39B | 4.86 | 10.70% | 2.80% | 2.39% | 46.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$433.33B | 7.80 | 11.64% | 2.05% | 48.94% | 36.64% | |
63 Neutral | HK$182.44B | 6.38 | 9.27% | 2.92% | 28.52% | 6.24% | |
62 Neutral | HK$89.30B | 6.25 | 6.85% | 3.48% | 24.21% | 75.20% |